On which exchange is ZIOPHARM Oncology, Inc. traded?
We are eligible for trading on the NASDAQ.
What is ZIOPHARM Oncology's ticker symbol?
The ticker symbol under which we trade is "ZIOP"
When did the company commence operations?
ZIOPHARM, Inc., our private company predecessor, commenced operations in January 2004. In September 2005, ZIOPHARM, Inc. merged with a public reporting company named EasyWeb Inc. to form ZIOPHARM Oncology, Inc.
Where is ZIOPHARM Oncology located?
Our executive headquarters are located at 1180 Avenue of the Americas, 19th Floor, New York, NY 10036. Our operations are located in Boston, MA.
When did ZIOPHARM Oncology "go public?"
In September 2005, ZIOPHARM, Inc. merged with a public reporting company named EasyWeb Inc. to form ZIOPHARM Oncology, Inc. Following the merger, ZIOPHARM Oncology, Inc. remains a public reporting company.
Who is ZIOPHARM Oncology's transfer agent?
ZIOPHARM Oncology's transfer agent is:
American Stock Transfer & Trust Company
6201 15th Avenue,
Brooklyn, New York 11219
Attn: Shareholder Services
1-877-248-6417 or 1-718-921-8317
How do I make changes to, or find out information about, my stock certificate?
Please contact our transfer agent (as above).
How can I replace my lost stock certificates?
Contact our transfer agent (as above).
Can I purchase shares of ZIOPHARM Oncology stock directly from the company?
No. ZIOPHARM Oncology does not currently have a direct stock purchase plan and is not offering to sell shares of its stock to the public
Who are the members of the Board of Directors and executive management? Who is on the Medical Advisory Board?
Our fiscal year coincides with the calendar year. As a result, our fiscal year end is December 31st each year.
How can I get information on healthcare conferences ZIOPHARM Oncology participates in?
Please visit the Investor Relations pages under events. Please click here.
How can I get news updates concerning ZIOPHARM Oncology?
Please click here to be directed to the email alerts page.
Has ZIOPHARM Oncology done a stock split?
ZIOPHARM, Inc. effected a 1 for 4 reverse stock split in March 2004 and EasyWeb, Inc. effected a 1 for 40 reverse stock split in August 2005. In connection with the September 2005 merger transaction, each outstanding share of ZIOPHARM, Inc. was exchanged for approximately 0.500974 shares of ZIOPHARM Oncology. Shares of EasyWeb, Inc. common stock outstanding at the time of the merger transaction were not affected by this exchange ratio. We have not declared any stock splits since our September 2005 merger transaction.
Do you have another question that hasn't been answered?
Please submit your question using the form below. Fields marked with an * are required.
